patholog
practic
increasingli
augment
molecular
test
improv
diagnost
patient
manag
polymeras
chain
reaction
pcr
foremost
amongst
techniqu
review
explain
principl
pcr
methodolog
factor
contribut
success
assay
key
pcr
techniqu
variat
revers
transcript
rt
pcr
quantit
realtim
q
pcr
describ
overview
provid
pcr
product
analys
review
includ
exampl
pcr
usag
clinic
practic
detect
infecti
genet
diseas
tumour
diagnost
molecular
forens
applic
specimen
ident
confirm
polymeras
chain
reaction
pcr
method
vitro
amplif
dna
sequenc
involv
autom
cycl
denatur
anneal
extens
synthesi
use
thermocycl
pcr
conceiv
develop
earli
kari
mulli
award
nobel
prize
chemistri
invent
techniqu
allow
sensit
detect
analysi
miniscul
quantiti
nucleic
acid
pcr
becom
establish
routin
method
patholog
diagnost
adapt
detect
infecti
agent
mutat
transloc
gene
amplif
molecular
forens
applic
includ
ident
test
review
cover
basic
pcr
assay
describ
pcr
method
variat
detail
current
patholog
applic
illustr
pcr
amplif
target
dna
sequenc
resourc
section
end
review
list
link
anim
pcr
demonstr
denatur
step
sampl
dna
render
singl
strand
heat
sampl
aim
anneal
step
hybrid
oligonucleotid
primer
specif
target
sequenc
complement
anneal
temperatur
depend
deoxyribonucleosid
triphosph
dntp
composit
length
primer
typic
amplif
product
three
pcr
cycl
figur
pcr
amplif
sampl
dna
denatur
heat
anneal
step
forwardupstream
primer
reversedownstream
primer
bind
target
sequenc
colour
violet
extens
step
dna
synthes
thermost
dna
polymeras
direct
orang
arrow
b
second
pcr
cycl
yield
forward
strand
fs
revers
strand
rs
dna
complementari
sequenc
ident
length
target
sampl
sequenc
c
doublestrand
amplicon
equival
target
gener
third
pcr
cycl
avail
exponenti
amplif
subsequ
round
pcr
step
vari
longer
min
depend
reaction
volum
size
amplicon
pcr
product
base
composit
length
thermost
dna
polymeras
activ
base
pair
bp
extend
per
minut
thermal
cycler
hardwar
specif
sampl
dna
dna
extract
patholog
sampl
sourc
amen
pcr
amplif
includ
dna
extract
biopsi
fresh
formalinfix
paraffinembed
ffpe
bodili
fluid
amniot
saliva
stool
urin
buccal
cell
scrape
cervic
scrape
fine
needl
aspir
gross
surgic
specimen
hair
root
peripher
blood
primari
cell
cultur
sampl
pcr
may
perform
purifi
crude
dna
prepar
howev
pcr
effici
may
compromis
cellular
debri
contamin
extract
reagent
case
crude
prepar
dna
extract
ffpe
specimen
gener
degrad
like
due
dna
shear
extract
consequ
dnaprotein
crosslinkag
induc
formalin
fixat
conveni
use
standard
volum
eg
dna
extract
pcr
although
may
accur
use
standard
dna
quantiti
eg
ng
excess
dna
may
inhibit
amplif
littl
dna
may
also
result
falseneg
pcr
result
buffer
ph
typic
maintain
use
trishclbas
buffer
ph
standard
condit
higher
temperatur
ph
fall
favour
taq
dna
polymeras
fidel
ingredi
includ
kcl
sometim
nh
promot
specif
primer
templat
anneal
nonion
deterg
bovin
serum
albumin
bsa
may
support
taq
dna
polymeras
enzym
stabil
magnesium
cation
mg
essenti
ingredi
mm
standard
concentr
stabil
interact
oligonucleotid
primer
templat
dna
taq
dna
polymeras
enzym
deoxyribonucleosid
triphosph
dntp
datp
dctp
dgtp
thymidin
ttp
also
refer
dttp
basic
dna
build
unit
dntp
gener
includ
reaction
concentr
label
dntp
includ
pcr
gener
label
amplicon
use
probe
situ
blot
hybrid
test
oligonucleotid
primer
rang
base
length
typic
concentr
rang
primer
may
label
fluoresc
dye
allow
fluorescencebas
detect
pcr
amplicon
primer
label
hapten
biotin
allow
amplicon
captur
eg
streptavidinco
microtitr
plate
amplicon
analys
use
revers
blot
hybrid
assay
thermost
dna
polymeras
heatstabl
enzym
taq
dna
polymeras
extract
thermu
aquaticu
isol
hotspr
dwell
bacterium
deinococcusthermu
phylum
requir
dna
synthesi
dnasernasefre
pure
water
pcr
final
reaction
volum
typic
vari
set
volum
adjust
volum
molecular
biolog
grade
water
pcr
techniqu
yield
abund
copi
target
dna
sequenc
theori
number
copi
target
doubl
everi
pcr
cycl
subsequ
second
cycl
see
figur
cycl
billionfold
amplif
would
expect
practic
exponenti
amplif
effici
may
occur
part
pcr
initi
cycl
effici
depend
eas
primer
background
human
genom
dna
sequenc
may
partial
homolog
primer
find
hybrid
specif
target
thereaft
exponenti
amplif
may
occur
limit
satur
event
pcr
product
outnumb
avail
thermost
polymeras
andor
primer
reagent
insuffici
support
amplif
pcr
amplicon
previous
synthes
experi
requir
optim
standard
effici
given
pcr
assay
falseneg
data
may
result
suboptim
design
pcr
test
potenti
compon
pcr
setup
manipul
improv
pcr
specif
sensit
primer
design
primer
sequenc
specif
target
especi
ensur
seed
extens
nontarget
primer
also
design
avoid
interor
intraprim
anneal
primer
similar
melt
temperatur
temperatur
dynam
equilibrium
dna
molecul
speci
doublestrand
form
singl
strand
temperatur
perfect
primer
target
anneal
expect
base
mismatch
depend
length
dna
sequenc
specif
dntp
sequenc
composit
sequenc
primer
concentr
low
concentr
may
favour
test
specif
reduc
sensit
vice
versa
high
concentr
mg
concentr
high
concentr
may
promot
test
sensit
lead
lower
specif
due
nonspecif
primer
anneal
nontarget
sequenc
lead
product
spuriou
amplicon
inadequ
concentr
may
result
lower
sensit
denatur
condit
thermost
dna
polymeras
optim
activ
high
temperatur
nonetheless
enzym
also
synthes
dna
lower
temperatur
thu
pcr
setup
room
temperatur
primer
may
anneal
nonspecif
singlestrand
dna
fragment
occur
consequ
sampl
extract
procedur
may
seed
dna
polymeras
activ
result
amplif
artefact
becom
target
amplif
pcr
cycl
proper
significantli
compromis
amplif
effici
intend
target
potenti
defect
avoid
use
hotstart
pcr
approach
hotstart
pcr
thermost
dna
polymeras
activ
activ
follow
initi
denatur
step
origin
accomplish
physic
ad
taq
dna
polymeras
reaction
overlaid
oil
denatur
step
preced
pcr
cycl
thermost
dna
polymeras
sinc
engin
hotstart
pcr
enzym
avail
undergo
conform
chang
high
temperatur
render
biolog
activ
altern
antibodybounddeactiv
taq
enzym
activ
high
temperatur
denatur
releas
antibodi
anneal
temperatur
anneal
temperatur
set
estim
calcul
dntp
sequenc
oligonucleotid
primer
typic
set
empir
test
usual
requir
find
optim
temperatur
temperatur
may
ensur
better
specif
expens
sensit
touchdown
pcr
initi
anneal
temperatur
set
degre
thereaft
anneal
temperatur
reduc
decrement
per
pcr
cycl
approach
help
ensur
earli
stage
pcr
primer
anneal
target
high
specif
lower
anneal
temperatur
later
pcr
cycl
favour
primer
hybrid
amplif
promot
assay
sensit
addit
varieti
reagent
may
ad
improv
pcr
amplif
includ
betain
n
n
ntrimethylglycin
dimethyl
sulphoxid
dmso
glycerol
reagent
may
enhanc
amplif
gcrich
dna
region
improv
strand
destabil
specif
prime
sensit
pcr
incur
potenti
defect
falseposit
data
due
amplif
crosscontamin
dna
exogen
sourc
strict
measur
requir
patient
sampl
collect
pcr
assay
ensur
authent
data
ideal
laboratori
space
arrang
dna
sampl
extract
pcr
setup
postpcr
manipul
occur
physic
distinct
area
pcrgrade
reagent
aliquot
dedic
equip
laboratori
coat
specif
area
util
pcr
product
previou
round
pcr
repres
major
potenti
sourc
contamin
nucleic
acid
contamin
pcr
setup
level
minim
varieti
measur
pcr
hood
usag
selfcontain
benchtop
unit
uv
light
dead
air
airflow
control
facil
short
wave
uv
nm
irradi
pcr
pipett
tip
tube
rack
pen
etc
caus
adjac
nucleic
acid
pyrimidin
form
dimer
nonamen
pcr
amplif
dna
polymeras
replac
dttp
dutp
pcr
amplicon
contain
dutp
instead
dttp
suscept
degrad
uracil
nglycosylas
ung
inclus
prepcr
incub
step
ung
therefor
elimin
crosscontamin
amplicon
prior
pcr
ung
inactiv
denatur
step
first
pcr
cycl
multipl
control
test
mandatori
pcr
assay
posit
control
requir
confirm
assay
suffici
detect
target
appropri
detect
sensit
therebi
avoid
falseneg
data
detect
threshold
pcr
test
describ
term
analyt
clinic
sensit
high
analyt
sensit
threshold
optim
allow
detect
lowest
trace
possibl
target
high
clinic
sensit
target
detect
threshold
correl
diseas
statu
construct
clinic
decisionmak
high
analyt
sensit
may
necessarili
equat
high
clinic
sensit
neg
control
multipl
known
neg
sampl
reagent
blank
dna
sampl
substitut
water
requir
demonstr
absenc
contamin
dna
pcr
reagent
therebi
avoid
falseposit
data
control
test
also
requir
confirm
given
patient
sampl
contain
nucleic
acid
suffici
puriti
integr
pcr
test
contamin
inhibit
revers
transcriptas
see
thermost
dna
polymeras
activ
nucleic
acid
inadequ
integr
amplicon
amplif
lead
falseneg
data
pcr
perform
cell
housekeep
target
confirm
sampl
suitabl
pcr
standard
thermocycl
includ
heat
lid
prevent
evapor
pcr
reagent
cycl
otherwis
reagent
overlaid
oil
typic
cycler
fit
thermal
block
either
ml
microtub
microtitr
plate
microtitr
plate
peltiereffect
thermoelectr
heat
cool
commonli
use
approach
support
rapid
heat
cool
temperatur
equilibr
throughout
thermal
block
quickli
thermal
cycler
ramp
temperatur
denatur
less
time
requir
complet
pcr
assay
varieti
method
use
analys
amplifi
product
amplicon
result
basic
type
pcr
assay
also
refer
endpoint
pcr
ie
final
product
accumul
pcr
cycl
materi
analysi
quantit
realtim
pcr
see
analysi
accomplish
thermal
cycler
hardwar
combin
dedic
softwar
analysi
gel
electrophoresi
simplest
form
analysi
consist
detect
dna
band
predict
size
follow
agaros
gel
electrophoresi
allow
plusminu
assess
presenc
target
amplicon
figur
percentag
agaros
composit
gel
determin
degre
size
resolut
exampl
agaros
gel
siev
band
rang
bp
distinguish
band
differ
length
finer
resolut
identifi
smaller
amplicon
polyacrylamid
gel
requir
exampl
polyacrylamid
gel
allow
analysi
product
rang
bp
distinct
band
differ
bp
gel
electrophoresi
use
restrict
fragment
length
polymorph
rflp
type
assay
interpret
pcr
depend
size
analysi
follow
restrict
endonucleas
digest
pcr
product
exampl
mutat
may
result
introduct
elimin
given
restrict
enzym
site
result
alter
rflp
pattern
compar
wildtyp
control
mutat
screen
also
perform
singlestrand
conform
polymorph
sscp
assay
use
polyacrylamid
gel
pcr
perform
normal
sampl
test
sampl
amplicon
render
singl
strand
subject
polyacrylamid
gel
electrophoresi
nativ
nondenatur
condit
singlestrand
amplicon
fold
conform
depend
sequencespecif
intramolecular
basepair
migrat
dna
gel
depend
size
charg
conform
presenc
mutant
sequenc
may
significantli
alter
singlestrand
fold
result
alter
migrat
rel
normal
control
polyacrylamid
gel
system
also
use
analysi
pcr
product
gener
primer
label
fluoresc
dye
system
includ
laserinduc
fluoresc
lif
detector
amplicon
migrat
past
lif
electrophoresi
light
emiss
fluoresc
dye
detect
lif
final
data
integr
system
hardwaresoftwar
present
term
peak
height
area
rel
fluoresc
emiss
scale
repres
dna
amplicon
fragment
refer
dna
size
marker
singl
base
differ
distinguish
blot
hybrid
theori
pcr
assay
result
sole
amplif
target
sequenc
test
design
howev
unpredict
amplicon
may
sometim
detect
hybrid
pcr
product
targetspecif
probe
use
confirm
ident
given
amplicon
southern
blot
hybrid
dna
transfer
gel
onto
nylon
membran
blot
hybrid
label
probe
specif
target
interest
detect
probe
label
affirm
amplif
intend
sequenc
dot
blot
hybrid
may
obviat
need
gel
electrophoresi
aliquot
pcr
product
heat
denatur
spot
onto
nylon
membran
dot
blot
hybrid
label
probe
detect
label
indic
presenc
assay
target
sequenc
figur
reverselin
blot
hybrid
allow
screen
pcr
product
multipl
target
assay
nylon
membran
spot
array
differ
probe
pcr
product
amplifi
label
dnpt
label
primer
hybrid
blot
amplicon
label
detect
site
hybrid
spot
probe
exampl
reverselin
blot
hybrid
assay
use
identifi
specif
human
papillomaviru
hpv
genotyp
amplifi
cervic
scrape
specimen
line
blot
avail
spot
probe
differ
hpv
genotyp
detect
hpv
amplicon
label
indic
hpv
genotyp
present
specimen
sequenc
analysi
pcr
product
may
repres
gold
standard
character
identif
pcr
product
howev
presenc
mix
wildtyp
mutant
sequenc
specimen
may
confound
mutat
detect
sequenc
recent
develop
pyrosequenc
techniqu
pyrosequenc
inc
westborough
usa
may
overcom
potenti
defect
allow
simultan
detect
mix
genotyp
within
sampl
pcr
techniqu
proven
highli
adapt
enabl
wide
rang
clinic
research
applic
blot
hybrid
dot
blot
hybrid
use
confirm
pcr
amplicon
ident
exampl
sampl
test
human
papillomaviru
hpv
posit
pcr
spot
onto
nylon
membran
hybrid
biotinlabel
probe
hybrid
biotin
label
detect
streptavidinalkalin
phospatas
conjug
nitroblu
tetrazolium
substrat
multiplex
pcr
support
simultan
amplif
one
target
sequenc
use
multipl
primer
pair
set
primer
set
design
yield
amplicon
distinguish
size
primer
may
label
differ
fluorophor
yield
amplicon
distinguish
electrophoresi
util
autom
lif
detector
realtim
pcr
altern
primer
set
amplifi
target
similar
size
may
discrimin
hybrid
label
probe
gener
four
uniqu
target
sequenc
amplifi
multiplex
pcr
assay
difficulti
ensur
pcr
sensit
specif
effici
multipl
target
eas
data
interpret
consensu
pcr
use
amplifi
singl
target
variabl
sequenc
multipl
target
similar
common
sequenc
consensu
primer
contain
one
mismatch
primer
sequenc
target
complement
usual
primer
design
mismatch
occur
region
primer
exampl
gener
primer
gp
pcr
assay
detect
hpv
use
two
consensu
primer
detect
least
differ
hpv
type
two
primer
contain
mismatch
depend
hpv
genotyp
gp
primer
design
region
hpv
gene
conserv
across
hpv
genotyp
degener
pcr
approach
also
use
amplif
target
variabl
sequenc
regular
oligonucleotid
primer
code
term
c
g
degener
primer
includ
code
allow
altern
base
given
site
primer
sequenc
exampl
w
primer
sequenc
indic
base
site
indic
c
h
indic
c
v
indic
c
g
code
allow
possibl
substitut
way
primer
design
refer
known
variabl
specif
sequenc
synthes
result
pool
primer
slightli
differ
sequenc
improv
amplif
target
genet
variabl
exampl
primer
amplifi
differ
hpv
type
sequenc
code
primer
code
indic
inosin
hybrid
datp
dctp
dgtp
dttp
nest
pcr
method
improv
pcr
sensit
specif
initi
standard
pcr
reaction
aliquot
pcr
product
taken
second
round
pcr
primer
design
amplifi
smaller
dna
region
within
primari
amplicon
secondari
primer
nest
use
second
round
pcr
favour
highli
sensit
assay
use
second
set
primer
design
specif
first
round
amplicon
favour
specif
rtpcr
figur
also
see
resourc
section
allow
investig
rna
express
via
pcr
thermost
dna
polymeras
requir
dna
substrat
first
step
rtpcr
convers
total
rna
dnafre
prepar
mrna
singlestrand
complementari
dna
cdna
two
commonli
use
revers
transcriptas
enzym
avian
myeloblastoma
viru
amv
moloney
murin
leukaemia
viru
mmulv
revers
transcriptas
three
differ
primer
strategi
may
use
synthesi
cdna
oligodt
primer
specif
amplif
mrna
random
hexam
nonam
oligonucleotid
primer
specif
gene
sequenc
interest
cdna
templat
taken
use
standard
pcr
sequencespecif
primer
altern
rtpcr
perform
onetub
reaction
consid
primer
design
inclus
revers
transcriptas
taq
dna
polymeras
addit
gener
determin
standard
pcr
success
rtpcr
effici
depend
rna
sampl
qualiti
effect
revers
transcriptas
step
standard
endpoint
pcr
final
product
obtain
pcr
cycl
materi
data
interpret
whilst
endpoint
pcr
semiquantit
essenti
qualit
assay
qpcr
use
accur
quantif
dna
rnacdna
target
sampl
qpcr
requir
special
thermal
cycler
includ
light
excit
sourc
record
fluoresc
signal
output
gener
pcr
cycl
pcr
reaction
set
microtitr
plate
rather
microtub
light
emiss
collect
via
thermocycl
lid
exponenti
pcr
phase
pcr
effici
approach
ingredi
qpcr
similar
standard
pcr
also
requir
inclus
fluoresc
emitt
two
main
qpcr
strategi
fluoresc
reson
energi
transfer
fret
refer
phenomenon
wherebi
donor
fluorophor
transfer
nonradi
energi
acceptor
fluorophor
close
nm
proxim
varieti
qpcr
approach
util
fret
technolog
first
wide
use
approach
taqman
requir
use
oligonucleotid
probe
complementari
site
within
amplicon
figur
resourc
section
taqman
probe
label
fluoresc
report
dye
eg
fam
fluoresc
quencher
dye
eg
tamra
anneal
step
pcr
cycl
taqman
probe
hybrid
target
fam
fluoresc
emiss
suppress
despit
excit
due
proxim
tamra
extens
step
taq
dna
polymeras
begin
synthes
dna
primer
upstream
probe
bind
site
taq
dna
polymeras
possess
exonucleas
activ
cleav
fam
probe
also
degrad
probe
extens
proce
longer
juxtapos
tamara
quencher
fam
fluorophor
emiss
measur
fretbas
qpcr
assay
use
molecular
beacon
scorpion
probe
sybr
green
fret
approach
increas
fluoresc
emiss
record
pcr
cycl
cyclebycycl
data
collect
basi
quantit
interpret
data
interpret
standard
curv
analysi
raw
data
follow
qpcr
assay
present
plot
fluoresc
unit
x
axi
versu
number
cycl
axi
figur
threshold
cycl
c
valu
defin
number
cycl
take
amplicon
detect
threshold
given
sampl
threshold
select
repres
level
fluoresc
significantli
background
fluoresc
within
exponenti
pcr
phase
qpcr
perform
control
sampl
known
dnarna
concentr
allow
construct
straight
line
standard
curv
c
versu
log
known
dnarna
copi
number
copi
number
unknown
sampl
infer
compar
sampl
c
valu
standard
curv
figur
doublestrand
dna
begin
melt
denatur
temperatur
depend
amplicon
length
base
sequenc
relationship
express
melt
curv
melt
peak
exampl
sybr
green
fluoresc
greatest
intens
doublestrand
dna
dna
melt
fluoresc
emiss
decreas
melt
curv
plot
fluoresc
intens
rel
temperatur
reflect
sequenc
charact
amplicon
effici
pcr
yield
singl
narrow
peak
repres
target
amplicon
pcr
melt
curv
data
also
use
compar
normal
test
sampl
presenc
point
mutat
eg
factor
v
leiden
mutat
singl
nucleotid
polymorph
snp
eg
defin
genet
diseas
suscept
drug
respons
differ
strain
microorgan
alter
dntp
sequenc
result
chang
melt
curv
given
amplicon
point
mutationsnp
pcr
short
duplex
melt
curv
assay
involv
addit
fluorophorelabel
oligonucleotid
probe
pcr
setup
addit
regular
primer
complet
pcr
perform
realtim
thermal
cycler
dissoci
probe
amplicon
ampliconprob
heteroduplex
measur
slowli
heat
sampl
regist
chang
fluorophor
emiss
probe
span
mutat
snp
site
incur
probetoamplicon
dntp
mismatch
result
lower
therefor
alter
melt
peak
profil
rel
probe
anneal
perfect
homolog
figur
melt
curv
analysi
technolog
patent
roch
appli
scienc
indianapoli
usa
qpcr
control
melt
curv
data
assess
confirm
given
qpcr
assay
specif
amplifi
intend
target
alon
qrtpcr
assay
also
requir
proof
genom
dna
present
rna
sampl
exampl
includ
neg
control
rt
enzym
absent
sampl
setup
differ
amount
puriti
integr
dna
rna
sampl
correct
way
normal
accomplish
perform
qpcr
housekeep
sequenc
dehydrogenas
gapdh
sampl
well
known
control
amount
infer
sampl
target
copi
number
correct
rel
number
cell
sampl
estim
gapdh
data
method
variat
amplif
refractori
mutat
system
arm
pcr
involv
anneal
targetspecif
primer
sequenc
interest
dna
synthes
dna
polymeras
direct
consequ
hybrid
primer
target
especi
critic
polymeras
activ
raw
melt
curv
fluoresc
data
demonstr
decreas
fluoresc
emiss
homozyg
wild
type
homozyg
mutant
heterozyg
genotyp
temperatur
increas
becom
separ
c
first
neg
deriv
fluoresc
versu
temperatur
dfdt
graph
show
peak
differ
melt
temperatur
tm
melt
peak
indic
homozyg
wild
type
genotyp
higher
tm
sequenc
mismatch
probe
mutantsnp
genotyp
sampl
contain
heterozyg
genotyp
sequenc
display
two
peak
temperatur
respect
wild
type
mutant
sampl
proceed
arm
techniqu
exploit
biolog
detect
point
mutat
snp
base
insertionsdelet
simplest
form
techniqu
requir
three
primer
one
primer
cp
common
altern
form
given
allel
second
primer
design
match
defin
base
specif
one
allel
form
third
primer
specif
altern
allel
two
separ
pcr
perform
one
primer
pair
one
primer
pair
common
primer
forward
primer
second
third
primer
revers
primer
vice
versa
pcr
fail
termin
dntp
primer
match
target
sequenc
use
approach
possibl
tell
patient
homozyg
heterozyg
given
allel
form
homozyg
patient
yield
one
amplicon
depend
allel
present
wherea
heterozyg
patient
yield
amplicon
combin
arm
assay
develop
detect
varieti
mutat
includ
associ
cystic
fibrosi
myeloprolif
disord
mutat
la
pcr
stand
long
accur
pcr
allow
amplif
sequenc
kb
length
process
number
nucleotid
ad
polymeras
enzym
dissoci
templat
taq
dna
polymeras
limit
standard
taq
dna
polymeras
introduc
mismatch
base
rel
sampl
templat
averag
everi
nucleotid
subsequ
pcr
cycl
mismatch
lead
taq
dna
polymeras
dissoci
secondari
templat
strand
therebi
restrict
length
amplicon
synthes
gener
standard
pcr
use
amplifi
sequenc
greater
kb
la
pcr
taq
dna
polymeras
combin
thermost
dna
polymeras
proofread
capac
eg
pfu
dna
polymeras
deriv
pyrococcu
furiosu
combin
increas
process
fold
methyl
statu
test
hyperor
hypomethyl
dna
cytosin
residu
may
import
marker
cancer
diseas
condit
gener
hypermethyl
associ
loss
gene
function
methyl
cytosin
may
found
gcrich
region
human
genom
distinguish
pcr
dna
sampl
first
treat
bisulphit
nonmethyl
dctp
convert
dutp
pcr
uracil
replac
thymidin
residu
yield
dttp
net
effect
convers
dctp
noncompl
dttp
methyl
dctp
undergo
chemic
chang
follow
bisulphit
exposur
complementari
base
dgtp
synthes
pcr
thu
methyl
statu
given
gene
infer
follow
bisulphit
treatment
pcr
amplicon
sequenc
restrict
endonucleas
assay
use
enzym
recogn
recogn
sequenc
subject
dctp
dttp
alter
pcrbase
assay
develop
extens
rang
clinic
applic
broadli
class
test
infecti
agent
mutationsmicrosatellit
repeat
expans
transloc
event
ident
testingmolecular
forens
bacteri
fungal
parasit
viral
infect
detect
pcr
mani
instanc
qualit
detect
infecti
agent
per
se
suffici
diagnost
purpos
exampl
detect
chlamydia
trachomati
neisseria
gonorrhoea
defin
diseas
statu
instanc
quantit
assay
may
critic
part
patient
manag
algorithm
exampl
infecti
agent
load
may
import
indic
therapi
respons
andor
emerg
resist
infect
patient
human
immunodefici
viru
hiv
hepat
b
viru
hbv
hepat
c
viru
hcv
qpcr
monitor
organ
transplant
recipi
cytomegaloviru
cmv
epsteinbarr
viru
ebv
jcbk
virus
perform
predict
associ
diseas
relaps
antivir
medic
infecti
agent
screen
pcr
includ
list
tabl
numer
molecular
genet
disord
character
definit
autosom
recess
ar
autosom
domin
ad
xlink
mitochondri
mutat
jew
aj
associ
condit
taysach
diseas
canavan
diseas
fanconi
anaemia
group
c
hereditari
haemochromatosi
spinal
muscular
atrophi
ad
disord
sever
ad
disord
achondroplasia
fgfr
geneassoci
condit
confirm
mutat
detect
pcr
also
rang
ad
disord
character
abnorm
nucleotid
repeat
unit
expans
microsatellit
repeat
sequenc
also
call
short
tandem
repeat
str
base
length
common
throughout
human
genom
earli
found
number
neuromuscular
diseas
associ
abnorm
high
number
trinucleotid
repeat
unit
exampl
patient
huntington
diseas
hd
excess
number
cag
repeat
unit
hd
gene
locat
chromosom
normal
subject
cag
commonli
repeat
time
patient
hd
may
repeat
ad
repeat
expans
disord
includ
myoton
dystrophi
type
spinocerebellar
ataxia
sca
friedrich
ataxia
frda
abnorm
expans
detect
pcr
use
primer
flank
region
contain
trinucleotid
repeat
follow
gel
electrophoresi
gaug
amplicon
size
assay
may
also
combin
southern
blot
hybrid
coagulopathi
mutationrel
disord
also
screen
pcr
factor
v
leiden
prothrombin
mutat
detect
pcrrflp
melt
curv
analysi
perform
realtim
thermal
cycler
xlink
disord
abnorm
repeat
expans
also
found
associ
fragil
x
syndrom
gene
duplic
may
found
xlink
muscular
dystrophi
becker
muscular
dystrophi
bmd
duchenn
muscular
dystrophi
dmd
xlink
point
mutat
may
found
bmd
dmd
xlink
adrenoleucodystophi
sarcoma
leukaemia
classifi
term
definit
transloc
molecular
level
result
gene
fusion
lead
express
abnorm
gene
transcript
rtpcr
wide
use
detect
chimer
mrna
construct
assist
tumour
diagnosi
ident
test
commonli
perform
multiplex
pcr
microsatellit
repeat
unit
pcr
perform
use
primer
flank
microsatellit
repeat
region
also
includ
uniqu
genom
sequenc
microsatellit
unit
repeat
variabl
number
time
given
chromosom
locu
mani
microsatellit
highli
polymorph
respect
number
repeat
given
allel
also
highli
heterozygot
within
popul
analysi
number
repeat
extent
popul
heterozygos
allow
calcul
probabl
match
microsatellit
amplicon
differ
individu
typic
minimum
four
microsatellit
loci
screen
pcr
ident
test
exampl
gammastr
quadriplex
assay
promega
corpor
madison
wi
usa
amplifi
four
microsatellitecontain
loci
figur
probabl
two
caucasian
individu
match
amplicon
four
loci
addit
eight
loci
ad
match
probabl
patholog
practic
microsatellit
pcr
use
resolv
issu
question
specimen
ident
figur
microsatellit
pcr
analysi
also
perform
patern
test
monitor
establish
donor
bone
marrow
tissu
recipi
qualiti
control
numer
pcr
assay
associ
patholog
practic
common
ad
hoc
usag
exampl
mayo
medic
laboratori
rochest
mn
usa
mayoaccess
test
catalog
list
pcrbase
test
applic
test
may
regul
individu
molecular
diagnost
laboratori
accord
consensu
criteria
may
nonetheless
vari
procedur
detail
interpret
one
institut
anoth
date
rel
test
standard
nation
intern
criteria
consist
applic
interpret
qualiti
control
one
institut
anoth
tabl
detail
pcrbase
assay
current
approv
clear
fda
standard
use
usa
pcr
wide
use
dna
amplif
techniqu
nevertheless
pcr
limit
two
major
concern
alreadi
mention
potenti
amplif
sampl
contamin
dna
result
falseposit
data
amplif
unintend
target
sequenc
compromis
data
interpret
inadequ
pcr
design
optim
may
lead
impair
pcr
effici
result
falseneg
result
falseneg
data
may
also
occur
due
presenc
contamin
specimen
nucleic
acid
extract
pcr
may
also
fail
discrimin
abnorm
mutat
high
background
normal
dna
specimen
number
altern
assay
develop
nucleic
acid
amplif
adapt
clinic
diagnost
includ
techniqu
direct
amplif
nucleic
acid
target
ligas
chain
reaction
eg
develop
detect
chlamydia
trachomati
transcriptionmedi
amplif
eg
mycobacterium
tuberculosi
test
stranddisplac
amplif
eg
legionella
pneumophilia
test
techniqu
gener
amplifi
signal
probe
hybrid
target
nucleic
acid
method
includ
branch
dna
ident
test
patient
biopsi
sampl
contain
tissu
fragment
featur
incongru
known
clinic
paramet
patient
dna
extract
fragment
sampl
compar
dna
sampl
known
patient
sampl
b
use
microsatellitebas
ident
assay
gammastr
promega
corp
madison
wi
usa
multiplex
pcr
test
involv
primer
pair
four
loci
chromosom
includ
tetranucleotid
repeat
unit
gener
amplicon
distinct
size
rang
primer
label
fluoresc
dye
detect
follow
capillari
gel
electrophoresi
genet
analys
system
although
match
amplicon
sampl
b
locu
known
patient
b
heterozyg
four
loci
indic
two
peak
measur
fluoresc
unit
wherea
sampl
homozyg
two
loci
indic
one
peak
addit
amplicon
size
differ
indic
exampl
allel
size
differ
one
two
tetranucleotid
repeat
unit
data
confirm
pathologist
suspicion
patient
sampl
crosscontamin
note
reduc
level
amplif
locu
consequ
use
dna
extract
formalinfix
paraffinembed
ffpe
tissu
dna
extract
ffpe
sourc
tend
degrad
consequ
fewer
fulllength
copi
larger
target
sequenc
compar
shorter
one
start
sampl
